← Back to Search

Dietary Habits for Post-Bariatric Surgery Weight Loss

N/A
Waitlist Available
Led By Frank Scheer, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Bariatric surgery (sleeve gastrectomy) patients
Be between 18 and 65 years old
Must not have
Insulin-dependent diabetes
Anemia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 4 weeks (post-intervention)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how different diets affect weight loss in patients who have had bariatric surgery.

Who is the study for?
This trial is for individuals who have undergone bariatric surgery, specifically sleeve gastrectomy, and are not currently smokers or dependent on drugs or alcohol. It's also important that they don't have bipolar disorder, anemia, PTSD, insulin-dependent diabetes or haven't done shift work in the past year.
What is being tested?
The study is examining how following a specific dietary habits plan can influence weight loss results after patients have had bariatric surgery. The goal is to see if these dietary changes improve the effectiveness of the surgery.
What are the potential side effects?
Since this trial focuses on dietary habits rather than medication or invasive procedures, side effects may include gastrointestinal discomfort due to diet change but are generally expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a sleeve gastrectomy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I use insulin to manage my diabetes.
Select...
I have anemia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 4 weeks (post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 4 weeks (post-intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Post-intervention change in self-rated hunger
Secondary study objectives
Change in caloric intake
Change in energy expenditure
Change in glucose tolerance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group BExperimental Treatment1 Intervention
Subject will be advised to follow dietary habits plan B. Since this is a single blind study, the details of the dietary interventions cannot be released during recruitment stage, but will be made public once enrollment closes.
Group II: Group AExperimental Treatment1 Intervention
Subject will be advised to follow dietary habits plan A. Since this is a single blind study, the details of the dietary interventions cannot be released during recruitment stage, but will be made public once enrollment closes.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,670 Previous Clinical Trials
11,878,222 Total Patients Enrolled
47 Trials studying Obesity
278,080 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,944 Previous Clinical Trials
47,799,788 Total Patients Enrolled
255 Trials studying Obesity
211,632 Patients Enrolled for Obesity
Frank Scheer, PhDPrincipal InvestigatorBrigham and Women's Hospital
4 Previous Clinical Trials
516 Total Patients Enrolled
2 Trials studying Obesity
444 Patients Enrolled for Obesity
Ali Tavakkoli, MDPrincipal InvestigatorBrigham and Women's Hospital
3 Previous Clinical Trials
464 Total Patients Enrolled
2 Trials studying Obesity
444 Patients Enrolled for Obesity

Media Library

Dietary habits plan Clinical Trial Eligibility Overview. Trial Name: NCT03482986 — N/A
Obesity Research Study Groups: Group A, Group B
Obesity Clinical Trial 2023: Dietary habits plan Highlights & Side Effects. Trial Name: NCT03482986 — N/A
Dietary habits plan 2023 Treatment Timeline for Medical Study. Trial Name: NCT03482986 — N/A
~4 spots leftby May 2025